DIABETES & PANCREATITIS Distinct Roles of Beta Cell Mass and Function during Type 1 Diabetes Onset and Remission Scientists demonstrate that infiltration reduces beta cell mass prior to diabetes and, together with emerging hyperglycemia, affects beta cell function. After immune intervention persisting hyperglycemia prevents functional recovery, but promotes beta cell mass increase in mouse islets. [Diabetes] Abstract Exercise Increases Pancreatic β-Cell Viability in a Model of Type 1 Diabetes through IL-6 Signaling Scientists investigated how exercise signals β cells in type 1 diabetes condition. Islets from control mice and β-cell lines were incubated with serum from control or trained mice or medium obtained from 5-aminoimidazole-4 carboxamide1-β-D-ribofuranoside-treated C2C12 skeletal muscle cells. [FASEB J] Abstract Beta-Cell Destruction and Preservation in Childhood and Adult Onset Type 1 Diabetes Researchers performed whole pancreas analyses in two type 1 diabetes (T1D) cases, one of childhood onset along with an adult onset case. Both cases were matched for age and gender with control subjects. Striking regional differences in beta-cell loss were observed in both T1D cases, with severity of loss in the order of tail > body > head regions. [Endocrine] Abstract Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling Using a coculture system containing human embryonic stem cell-derived progenitors and endothelial cells, scientists found that endothelial cells play a stage-dependent role in pancreatic development, in which they maintain pancreatic progenitor self-renewal and impair further differentiation into hormone-expressing cells. [Stem Cell Rep] Full Article | Graphical Abstract PANCREATIC CANCER Pharmacological Activation of Myosin II Paralogs to Correct Cell Mechanics Defects Scientists demonstrate 4-hydroxyacetophenone’s ability to convert the mechanical profile of metastasis-derived pancreatic cancer cells toward a normal WT-like state. [Proc Natl Acad Sci USA] Abstract | Press Release Intracellular Annexin A2 Regulates NF-κB Signaling by Binding to the p50 Subunit: Implications for Gemcitabine Resistance in Pancreatic Cancer The role of intracellular annexin A2 (ANXA2) was investigated in a pancreatic cancer cell line. Researchers determined whether ANXA2 is involved in NF-κB signaling pathways. [Cell Death Dis] Full Article CD95 Promotes Metastatic Spread via Sck in Pancreatic Ductal Adenocarcinoma In silico analysis of RNA profiles of 36 pancreatic ductal adenocarcinomas (PDAC) reveals an association of the expression of CD95 with epithelial-mesenchymal transition and stemness that was validated in cancer stem cells isolated from PDAC surgical specimens. CD95 expression was also higher in metastatic pancreatic cells than in primary PDAC. [Cell Death Dis] Full Article Engineered Adenoviruses Combine Enhanced Oncolysis with Improved Virus Production by Mesenchymal Stromal Carrier Cells Scientists show that an Ad5/3 chimeric oncolytic adenovirus capsid, containing the adenovirus serotype 3 cell-binding domain, strongly increases the entry into human bone marrow-derived mesenchymal stromal cells and into established and primary pancreatic cancer cells. [Int J Cancer] Abstract Ratio of Phosphorylated HSP27 to Nonphosphorylated HSP27 Biphasically Acts as a Determinant of Cellular Fate in Gemcitabine-Resistant Pancreatic Cancer Cells After acquisition of gemcitabine resistance, cancer cells showed higher activity of NF-κB. NF-κB activity, as well as colony formation in gemcitabine-resistant pancreatic cancer cells, was significantly decreased by HSP27 downregulation and subsequent TRAIL treatment, showing that HSP27 was a common network mediator of gemcitabine/TRAIL-induced cell death. [Cell Signal] Abstract |